ECM
CHRS icon

ExodusPoint Capital Management’s Coherus Oncology CHRS Stock Holding History

ExodusPoint Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-134,038
Closed -$139K – 1592
2024
Q3 		$139K Buy
+134,038
New +$184K ﹤0.01% 1489
2024
Q2 		– Sell
-16,211
Closed -$39K – 1576
2024
Q1 		$39K Buy
+16,211
New +$39.9K ﹤0.01% 1437
2023
Q2 		– Sell
-86,909
Closed -$594K – 1891
2023
Q1 		$594K Buy
86,909
+55,308
+175% +$429K ﹤0.01% 1290
2022
Q4 		$250K Sell
31,601
-112,000
-78% -$862K ﹤0.01% 1407
2022
Q3 		$1.38M Buy
+143,601
New +$1.45M 0.02% 962
2022
Q2 		– Sell
-50,968
Closed -$658K – 1990
2022
Q1 		$658K Buy
50,968
+30,645
+151% +$390K 0.01% 1380
2021
Q4 		$324K Sell
20,323
-6,756
-25% -$118K ﹤0.01% 1629
2021
Q3 		$435K Buy
+27,079
New +$397K 0.01% 1469
2021
Q2 		– Sell
-50,716
Closed -$741K – 2394
2021
Q1 		$741K Buy
+50,716
New +$861K 0.01% 1104
2020
Q4 		– Sell
-13,345
Closed -$245K – 2004
2020
Q3 		$245K Buy
+13,345
New +$248K ﹤0.01% 1384
2019
Q3 		– Sell
-104,978
Closed -$2.32M – 1359
2019
Q2 		$2.32M Buy
104,978
+67,916
+183% +$1.18M 0.09% 141
2019
Q1 		$506K Buy
+37,062
New +$494K 0.04% 333

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

ExodusPoint Capital Management's CHRS Position: Q4 2024 in Review

ExodusPoint Capital Management sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 134,038 shares — an estimated $139K sold.

ExodusPoint Capital Management first reported a position in CHRS in Q1 2019 and held it in 12 quarters. The position peaked at $2.32M in Q2 2019. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.

  • ExodusPoint Capital Management reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 134,038 Coherus Oncology shares in Q4 2024, an estimated $139K.
  • ExodusPoint Capital Management first reported a position in Coherus Oncology in Q1 2019 and held it in 12 quarters.
  • ExodusPoint Capital Management's Coherus Oncology position peaked at $2.32M in Q2 2019.
  • 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.